LYMPHOMA PATIENTS

Clinical trials for LYMPHOMA PATIENTS explained in plain language.

Never miss a new study

Get alerted when new LYMPHOMA PATIENTS trials appear

Sign up with your email to follow new studies for LYMPHOMA PATIENTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New drug may keep platelets up during lymphoma chemo

Disease control Completed

This study tested whether the drug romiplostim can help prevent dangerously low platelet counts caused by chemotherapy in lymphoma patients. Eleven adults with lymphoma received romiplostim alongside their chemo to see if it could reduce the need for treatment delays, lower chemo…

Matched conditions: LYMPHOMA PATIENTS

Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control

Last updated May 01, 2026 16:00 UTC

LYMPHOMA PATIENTS

Get alerted when new LYMPHOMA PATIENTS trials appear

New drug may keep platelets up during lymphoma chemo